 |
|
Directly Observed Preventive TherapyTurning the Tide Against Tuberculosis
Michael R. Kohn, MBBS, FRACP;
Martha R. Arden, MD;
Jeanne Vasilakis, PNP;
I. Ronald Shenker, MD
Arch Pediatr Adolesc Med. 1996;150(7):727-729.
Abstract
| |
Objective
To compare compliance between directly observed preventive therapy and daily treatment for students with inactive (class II) tuberculosis.
Design
Cohort analytic study and cost-effectiveness analysis. Students found to be positive for purified protein derivative and having no abnormal chest x-ray films on mandated screening were advised to have prophylactic treatment with isoniazid. Treatment was either directly observed in the school health clinic or provided as daily therapy by the Department of Health. Treatment completion, age, sex, ethnicity, and recent immigration were compared between the 2 treatment groups.
Setting
A school-based clinic at an inner-city New York, NY, high school.
Results
In 1993,864 students were screened. The positive purified protein derivative rate was 19.3%. All 161 students had negative findings on chest x-ray films. Of the students, 105 (65.2%) were enrolled in the school-based clinic directly observed preventive therapy program, 22 were referred to the Department of Health for daily therapy, and 34 were excluded from the study before treatment. The 2 treatment groups did not differ in composition. Completion of therapy in the directly observed preventive therapy group (87.6%) was significantly greater than that in the daily therapy group (50%) (P=.001,  2=11.8) and that reported in the literature for programs other than directly observed preventive therapy (30%-70%). Directly observed preventive therapy was administered by existing personnel without additional expenditure.
Conclusion
Directly observed preventive therapy is an effective strategy that should be used in the school clinic setting to increase compliance with prophylactic treatment for tuberculosis.
Arch Pediatr Adolesc Med. 1996;150:727-729
Author Affiliations
From the Division of Adolescent Medicine, Department of Pediatrics, Schneider Children's Hospital, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
Holland et al.
Am. J. Respir. Crit. Care Med. 2009;179:1055-1060.
ABSTRACT
| FULL TEXT
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
Am. J. Respir. Crit. Care Med. 2005;172:1169-1227.
FULL TEXT
Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents
Pediatric Tuberculosis Collaborative Group
Pediatrics 2004;114:1175-1201.
ABSTRACT
| FULL TEXT
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
Horsburgh
NEJM 2004;350:2060-2067.
ABSTRACT
| FULL TEXT
Increasing Latino Adolescents' Adherence to Treatment for Latent Tuberculosis Infection: A Controlled Trial
Hovell et al.
AJPH 2003;93:1871-1877.
ABSTRACT
| FULL TEXT
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection . This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This Statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this Statement as it relates to infants and children were endorsed by the American Academy of Pediatrics (AAP), August 1999.
Am. J. Respir. Crit. Care Med. 2000;161:S221-247.
FULL TEXT
|
